Overall, these findings suggest that the psychopharmacological mechanism of HFE is mediated through regulation of the Kv4.2/ERK/CREB pathway to restore the hippocampal dysfunction and behavioral abnormalities in SPS+FS-treated mice, suggesting that HFE is a potential treatment for PTSD. Here, CREB1 is linked to post-traumatic stress disorder.